NCT03078205 is a NA clinical trial of The dual therapy in Failure After Assisted Reproductive Technology, sponsored by Chengdu University of Traditional Chinese Medicine.

Who is sponsoring NCT03078205?

NCT03078205 is sponsored by Chengdu University of Traditional Chinese Medicine.

What drugs are being tested in NCT03078205?

Interventions in NCT03078205: The dual therapy, The triple therapy.

What condition does NCT03078205 study?

NCT03078205 studies Failure After Assisted Reproductive Technology.

Is NCT03078205 still recruiting?

NCT03078205 is currently completed. Last updated 17 February 2020.

Last reviewed 2020-02-17 · How we verify

NCT03078205

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Observation on the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy

Completed NA Last updated 17 February 2020

What this trial tests

NA trial testing The dual therapy in Failure After Assisted Reproductive Technology in 100 participants. Completed in 1 April 2018.

Timeline

1 May 2016

Primary endpoint
1 January 2018

1 April 2018

Quick facts

Lead sponsor	Chengdu University of Traditional Chinese Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 May 2016
Primary completion	1 January 2018
Estimated completion	1 April 2018
Sites	1 location across China

Drugs / interventions tested

The dual therapy
The triple therapy — full drug profile →

Conditions studied

Failure After Assisted Reproductive Technology — all drugs for Failure After Assisted Reproductive Technology →

Sponsor

Chengdu University of Traditional Chinese Medicine

Who can join

Adults 20 to 42, female only, with Failure After Assisted Reproductive Technology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan. Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Efficacy and Safety of the Zhuyun Formula and Auricular Acupressure for the Infertile Women with Recurrent Implantation Failure: A Randomized Controlled Trial.
Zhou H, Zheng X, Xia W, Ma Q, et al · · 2022 · cited 1× · PMID 36267092 · DOI 10.1155/2022/5274638

Verify or expand the search:

Other Chengdu University of Traditional Chinese Medicine trials

Trials by the same sponsor.

NCT07404670 — Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety · NA · not yet recruiting
NCT07239284 — Efficacy and Safety of Endovenous Ablation for Relief of Knee Pain in Elderly Patients With Lower Extremity Varicose Vei · not yet recruiting
NCT07233616 — Risks and Benefits of Radiofrequency Ablation for Chronic Venous Insufficiency (CEAP C3-C6) in Patients Aged 80 and Over · recruiting
NCT07163312 — Knee Pain Relief After Endovenous Treatment for Lower Limb Varicose Veins: A Prospective Observational Study · not yet recruiting
NCT07208695 — Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients Wi · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03078205 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chengdu University of Traditional Chinese Medicine
Last refreshed: 17 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03078205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing